Bellicum Pharmaceuticals (NASDAQ:BLCM) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 14.9 % Shares of BLCM stock opened at $0.15 on Monday. The firm’s 50 day moving average price is […]
More Stories
Advisors Asset Management Inc. Makes New Investment in Cencora, Inc. (NYSE:COR)
Advisors Asset Management Inc. bought a new stake in Cencora, Inc. (NYSE:COR – Free Report) during the 1st quarter, according...
Hydro One (TSE:H) Hits New 1-Year High at $42.03
Shares of Hydro One Limited (TSE:H – Get Free Report) reached a new 52-week high on Wednesday . The company...
Advisors Asset Management Inc. Increases Stock Holdings in Herc Holdings Inc. (NYSE:HRI)
Advisors Asset Management Inc. lifted its position in Herc Holdings Inc. (NYSE:HRI – Free Report) by 9.2% in the first...
Advisors Asset Management Inc. Decreases Position in Principal Financial Group, Inc. (NYSE:PFG)
Advisors Asset Management Inc. lowered its stake in shares of Principal Financial Group, Inc. (NYSE:PFG – Free Report) by 12.2%...
Shell Asset Management Co. Buys 7,728 Shares of General Motors (NYSE:GM)
Shell Asset Management Co. lifted its position in General Motors (NYSE:GM – Free Report) (TSE:GMM.U) by 27.5% during the first...
Emergent BioSolutions (NYSE:EBS) Reaches New 52-Week High at $13.23
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) reached a new 52-week high on Wednesday . The company...